Aceclofenac with Serratiopeptidase
Aceclofenac with Serratiopeptidase is a combination medication that typically includes Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), and Serratiopeptidase, an enzyme with anti-inflammatory and fibrinolytic properties. This combination is commonly used to alleviate pain and inflammation.-Relief of pain and inflammation associated with osteoarthritis -Management of acute musculoskeletal conditions -Reduction of swelling and pain post-surgery
The dosage may vary based on individual patient characteristics and the severity of the condition. It is essential to follow the prescribed dosage and administration instructions provided by the healthcare professional.
-Hypersensitivity to Aceclofenac, Serratiopeptidase, or related NSAIDs -Active peptic ulcer -Severe renal or hepatic impairment -Pregnancy, especially in the third trimester
-Patients with a history of gastrointestinal disorders or bleeding tendencies -Individuals with impaired renal or hepatic function -Asthmatic patients with a history of aspirin or NSAID-induced bronchospasm -Avoid use in lactating mothers -Caution in elderly patients
Common side effects may include gastrointestinal disturbances (nausea, dyspepsia), skin rashes, and headache. Serious side effects such as gastrointestinal bleeding, renal impairment, and allergic reactions are possible and require immediate medical attention.
-Concurrent use with other NSAIDs may increase the risk of adverse effects. -Anticoagulants: Increased risk of bleeding. -Diuretics: Potential for reduced antihypertensive effect. -Methotrexate: Enhanced toxicity.